美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

台湾微脂体

7.00

0.0000

成交量：- -

成交额：- -

市值：2.95亿

市盈率：-10.52

高：7.00

开：7.00

低：7.00

收：7.00

52周最高：7.70

52周最低：4.07

股本：4,207.75万

流通股本：1,606.67万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.6656

每股收益(LYR):-0.8844

净资产收益率：-108.77%

总资产收益率：-34.73%

市净率：52.31

市盈率(LYR):-7.92

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

台湾微脂体

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.tlcbio.com

邮编：

- -

电话：

- -

传真：

- -

简介：

台湾微脂体股份有限公司于1997年11月10日注册成立。他们是一家临床阶段的专业制药公司，致力于将其专有的脂质组装药物输送平台与经批准的活性药物成分（API）相结合的同类最佳新型纳米药物的开发和商业化。他们的BioSeizer脂质制剂技术能够增加药物动力学（PK）控制和APIs在疾病或损伤部位的局部持续释放，并用于其TLC599，TLC399和TLC590程序。他们的NanoX靶向输送技术能够延长PK曲线并增强脂质体封装API在期望位点的分布，并用于其TLC178项目中。因为他们的产品候选人使用已经批准的API，因此他们有资格利用简化的505监管通路在美国进行审批。他们已经使用他们的专有技术平台来组装一个多样化的产品候选产品组合，以针对疼痛管理，眼科和肿瘤学领域未满足的医疗需求的重要领域。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/TLC/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLC\",,,,,undefined,":{"symbol":"TLC","market":"US","secType":"STK","nameCN":"台湾微脂体","latestPrice":7,"timestamp":1634328000000,"preClose":7,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":16066666,"shares":42077467,"eps":-0.665645,"marketStatus":"未开盘","change":0,"latestTime":"10-15 16:00:00 EDT","open":7,"high":7,"low":7,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.665645,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1781164800000},"marketStatusCode":0,"adr":0,"adrRate":2,"listingDate":1542344400000,"exchange":"NASDAQ","adjPreClose":7,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLC\",,,,,undefined,":{"symbol":"TLC","floatShares":16066666,"roa":"-34.73%","roe":"-108.77%","lyrEps":-0.884353,"shares":42077467,"dividePrice":0,"high":7,"amplitude":0,"preClose":7,"low":7,"week52Low":4.07,"pbRate":"52.31","week52High":7.7,"institutionHeld":0,"latestPrice":7,"eps":-0.665645,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.665645,"open":7,"prevYearClose":4.43},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-08-12","symbol":"TLC","fiscalQuarterEnding":"2021/06","expectedEps":-0.2,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-0.04},{"market":"US","date":"2021-05-14","symbol":"TLC","fiscalQuarterEnding":"2021/03","expectedEps":-0.24,"name":null,"time":"","type":"earning","dateTimestamp":1620964800000,"reportTimeType":"","actualEps":-0.08},{"market":"US","date":"2021-03-30","symbol":"TLC","fiscalQuarterEnding":"2020/12","expectedEps":-0.22,"name":null,"time":"","type":"earning","dateTimestamp":1617076800000,"reportTimeType":"","actualEps":-0.26},{"market":"US","date":"2020-10-28","symbol":"TLC","fiscalQuarterEnding":"2020/09","expectedEps":-0.22,"name":null,"time":"","type":"earning","dateTimestamp":1603857600000,"reportTimeType":"","actualEps":-0.2},{"market":"US","date":"2020-08-05","symbol":"TLC","fiscalQuarterEnding":"2020/06","expectedEps":-0.2,"name":null,"time":"","type":"earning","dateTimestamp":1596600000000,"reportTimeType":"","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TLC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.tlcbio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0382},{"period":"1month","weight":-0.0188},{"period":"3month","weight":0.0891},{"period":"6month","weight":0.0641},{"period":"1year","weight":0.2029},{"period":"ytd","weight":0.0638}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"台湾微脂体股份有限公司于1997年11月10日注册成立。他们是一家临床阶段的专业制药公司，致力于将其专有的脂质组装药物输送平台与经批准的活性药物成分（API）相结合的同类最佳新型纳米药物的开发和商业化。他们的BioSeizer脂质制剂技术能够增加药物动力学（PK）控制和APIs在疾病或损伤部位的局部持续释放，并用于其TLC599，TLC399和TLC590程序。他们的NanoX靶向输送技术能够延长PK曲线并增强脂质体封装API在期望位点的分布，并用于其TLC178项目中。因为他们的产品候选人使用已经批准的API，因此他们有资格利用简化的505监管通路在美国进行审批。他们已经使用他们的专有技术平台来组装一个多样化的产品候选产品组合，以针对疼痛管理，眼科和肿瘤学领域未满足的医疗需求的重要领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.036925},{"month":2,"riseRate":0.666667,"avgChangeRate":0.043492},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.057189},{"month":4,"riseRate":0.333333,"avgChangeRate":0.084853},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.007665},{"month":6,"riseRate":0.666667,"avgChangeRate":0.077597},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.002789},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.005402},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.03619},{"month":10,"riseRate":0,"avgChangeRate":-0.013222},{"month":11,"riseRate":0.5,"avgChangeRate":-0.002828},{"month":12,"riseRate":0.666667,"avgChangeRate":-0.000473}],"exchange":"NASDAQ","name":"台湾微脂体","nameEN":"Taiwan Liposome Company Ltd","securityTypeName":"存托凭证","adrRate":"1:2"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"TLC\",market:\"US\",,,undefined,":null}}